The ‘4S’ Pathway was designed to guide shifting needs in older adults with diabetes who are struggling with diabetes ...

Researchers have discovered in a new study that women diagnosed with gestational diabetes mellitus (GDM) earlier than 24 ...

HighTide Therapeutics Announces HTD1801 Meets the Primary Endpoints in Two Phase 3 Clinical Trials in Patients with Type 2 Diabetes Mellitus HONG KONG - April 15, 2025 (NEWMEDIAWIRE) - HighTide ...

Two out of the five mixtures tested were found to be associated with a higher incidence of type 2 diabetes, particularly one mixture containing different emulsifiers such as carrageenans ...

C-peptide's dual role involves protective mechanisms against DR and potential harmful effects in type 2 diabetes. Monitoring FCP levels is crucial for managing DR risk in patients with type 2 diabetes ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online March 27 in JAMA ...

There are no approved treatments for nonrelapsing secondary progressive multiple sclerosis. In a phase 3, double-blind, placebo-controlled, event-driven trial, we randomly assigned participants ...

Researchers reviewed data from more than 56 million pregnancies to examine the connection between diabetes and A.D.H.D., autism and intellectual disability. By Alisha Haridasani Gupta and Nina ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

While such systems are most commonly used by those with type 1 diabetes (T1D), evidence suggests ... meeting the noninferiority threshold (P = .009). A secondary endpoint, A1c, showed no ...